TipRanks
Is Bionano Stock Still Worth Buying After Its 2,300%-Plus Rally? Analyst Weighs In
To say it is all coming together nicely for Bionano Genomics (BNGO) would be a bit of an understatement. The life sciences company’s rise has been particularly eye-catching; Over the past 2 months, BNGO has surged by a breathtaking 2,344%. Investors have evidently gotten wise to the opportunity Bionano represents in the world of cytogenetics and genomics, due to the potential of its genome imaging…
Source link